PharmaShots | Incisive News in 3 Shots

Subscribe Now

avß6 Integrin

AbbVie Exercises its Option to License Morphosys' αvβ6 Integrin Inhibitor Program for Fibrotic Disease

AbbVie Exercises its Option to License Morphosys' αvβ6 Integrin Inhibitor Program for Fibrotic Disease

August 25, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us